Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

DEA vs DOC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

DOC Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

DOC Overall Winner 6-Pillar Tally: DEA 3 – 3 DOC Matrix Metrics: DEA 3 – 7 DOC

As of Nov 17, 2026, Healthpeak Properties, Inc. (DOC) is the stronger overall head-to-head candidate over Easterly Government Properties, Inc. (DEA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). DEA carries a Unified Composite Score of 45.1/100 (HOLD) at $21.76 (46.1x Forward P/E, 25.2% operating margin), whereas DOC carries 54.0/100 (HOLD) at $19.36 (141.7x Forward P/E, 15.7% operating margin).

  • Technical & Structure Timing Caution: DEA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.3); meanwhile DOC is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DEA vs DOC
DEA NYSE
Easterly Government Properties, Inc.
Real Estate Investment Trusts
$21.76
-0.59% 1D
Market Cap $1.1B
TTM Revenue $371M
Forward P/E 46.1x
Beta / 30D Vol 0.31β · 26% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 42.0 Fund 52.0 Flow 57.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.6%), weak momentum, RSI 38
RSI-14: 38.3 · SMA20: $22.48 · SMA50: $22.80
DOC NYSE Head-to-Head Winner
Healthpeak Properties, Inc.
Real Estate Investment Trusts
$19.36
-2.39% 1D
Market Cap $14.5B
TTM Revenue $3.06B
Forward P/E 141.7x
Beta / 30D Vol 0.38β · 29% Vol
Unified Composite Score
54.0 / 100 HOLD
Tech 48.0 Fund 54.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.7%) with fading momentum, RSI 45
RSI-14: 44.9 · SMA20: $19.61 · SMA50: $19.64

6-Pillar Scorecard Institutional Category Breakdown (DEA 3 – 3 DOC)

Columns: Metric · DEA · DOC
1. Valuation Multiples DOC
Forward P/E 46.1x 141.7x
Trailing P/E 76.1x 37.0x
PEG Ratio N/M 4.08x
EV / Revenue 7.4x 4.7x
2. Growth & Scale DOC
Revenue Growth (YoY) +8.8% +16.3%
Earnings Growth (YoY) +450.0% +68.2%
TTM Revenue (USD) $371M $3.06B
Market Cap $1.1B $14.5B
3. Profitability & Quality DEA
Gross Margin 67.5% 56.1%
Operating Margin 25.2% 15.7%
Net Profit Margin 3.9% 12.3%
Return on Equity (ROE) 1.1% 4.4%
4. Balance Sheet & Cash Flow DOC
Cash Generation (TTM) $161M $1.59B EBITDA
Cash Flow Margin 43.4% 51.8% EBITDA Mgn
Net Cash / Leverage $1.67B Net Debt (1.28x D/E) $11.41 Book/Sh · 4.4% ROE
Dividend Yield 8.18% 6.09%
5. Options & Positioning DEA
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 34.7% (8th %ile) 20.7% (25th %ile)
Put/Call OI Skew 4.08x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Distribution
6. R&D & Supply-Chain Moat DEA
OpEx & R&D Intensity 42.3% of Rev ($157M) 40.4% of Rev ($1.24B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role REIT - Office Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DEA (3) vs DOC (7)
Institutional Metric DEA DOC Criterion Row Edge
Market Capitalization
Scale
$1.1B $14.5B Larger Scale DOC
Trailing P/E Ratio
Valuation
76.1x 37.0x Lower Multiple DOC
Forward P/E Ratio
Valuation
46.1x 141.7x Lower Multiple DEA
Revenue Growth (YoY)
Growth
+8.8% +16.3% Higher Growth DOC
Operating Margin (TTM)
Profitability
25.2% 15.7% Higher Margin DEA
Net Profit Margin
Profitability
3.9% 12.3% Higher Margin DOC
Return on Equity (ROE)
Capital Efficiency
1.1% 4.4% Higher ROE DOC
52-Week Range Position
Momentum
22% ($21–$26) 51% ($16–$23) Stronger Trend DOC
Beta / 30D Volatility
Risk Regime
0.31β · 26% Vol 0.38β · 29% Vol Lower Realized Risk DEA
Unified Institutional Score
Composite Signal
45.1 / 100 (HOLD) 54.0 / 100 (HOLD) Higher Composite DOC
Trailing 12M Revenue (USD)
Operating Scale
$371M $3.06B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
67.5% 56.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 7.4x EV/Rev 4.08x PEG · 4.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$161M ($1.67B Net Debt (1.28x D/E)) $1.59B EBITDA ($11.41 Book/Sh · 4.4% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon DOC +3.89 pp
DEA: +1.35% · DOC: +5.24%
3M Horizon DOC +4.14 pp
DEA: -10.86% · DOC: -6.72%
6M Horizon DOC +8.1 pp
DEA: -7.76% · DOC: +0.34%
1Y Horizon DOC +10.82 pp
DEA: +0.79% · DOC: +11.61%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DEA vs DOC. Trailing 12-month operating profitability (DEA 25.2% vs DOC 15.7%) and valuation multiples (DEA 46.1x vs DOC 141.7x Forward P/E) are benchmarked directly in Pillar 4 below.

DEA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$371M
Gross Margin67.5%
Op. Margin25.2%
ROE / Fwd P/E1.1% · 46.1x
DOC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.06B
Gross Margin56.1%
Op. Margin15.7%
ROE / Fwd P/E4.4% · 141.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DEA CONSOLIDATION
100d in phase · OBV DISTRIBUTION
Current IV 34.7%
IV Percentile 8th %ile
Put/Call OI Skew 4.08x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact DEA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
DOC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 20.7%
IV Percentile 25th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DOC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DEA Moat Profile Scale & Operating Efficiency Moat
REIT - Office Operator
Competes within the REIT - Office value chain with $1.1B market capitalization and 25.2% operating margin.
OpEx & R&D Reinvestment 42.3% of Rev ($157M)
90D Engineering Disclosures 0 Published
DOC Moat Profile Scale & Operating Efficiency Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $14.5B market capitalization and 15.7% operating margin.
OpEx & R&D Reinvestment 40.4% of Rev ($1.24B)
90D Engineering Disclosures 0 Published

Investor FAQ DEA vs DOC Key Questions & Quantitative Answers

As of Nov 17, 2026, Healthpeak Properties, Inc. (DOC) is the stronger overall head-to-head candidate over Easterly Government Properties, Inc. (DEA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). DEA carries a Unified Composite Score of 45.1/100 (HOLD) at $21.76 (46.1x Forward P/E, 25.2% operating margin), whereas DOC carries 54.0/100 (HOLD) at $19.36 (141.7x Forward P/E, 15.7% operating margin). Technical & Structure Timing Caution: DEA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.3); meanwhile DOC is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

DOC leads the Growth & Scale pillar: DEA posts +8.8% YoY revenue growth and +450.0% YoY earnings growth on $371M TTM revenue (67.5% gross margin, 25.2% operating margin), compared with DOC at +16.3% YoY revenue growth and +68.2% YoY earnings growth on $3.06B TTM revenue (56.1% gross margin, 15.7% operating margin). On trailing 12-month operating scale, DEA generates $371M in USD-normalized revenue versus $3.06B for DOC. In operating R&D and SG&A reinvestment, DEA deploys 42.3% of Rev ($157M) (0 90-day corporate R&D disclosures) versus 40.4% of Rev ($1.24B) (0 disclosures) for DOC.

DOC screens cheaper on headline valuation multiples. DEA trades at 46.1x Forward P/E, 76.1x Trailing P/E, N/M PEG, and 7.4x EV/Revenue (43.4% FCF margin), whereas DOC trades at 141.7x Forward P/E, 37.0x Trailing P/E, 4.08x PEG, and 4.7x EV/Revenue (51.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DEA (1.1% ROE) versus DOC (4.4% ROE) capital efficiency.

In options market volatility and institutional positioning, DEA carries 34.7% implied volatility (8th %ile, Compressed (<25th %ile)), a 4.08x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.31β · 26% Vol realized risk). By comparison, DOC carries 20.7% implied volatility (25th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.38β · 29% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.